XML 20 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Millions
Total
Cumulative Effect Period Of Adoption Adjustment [Member]
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2018 $ 4,569.7 $ (2.4) $ 184.0 $ 3,541.9 $ 1,558.6 $ (2.2) $ (785.6) $ (0.2) $ 70.8
Beginning balance (in shares) at Dec. 31, 2018     184,000,000.0            
Net earnings 351.7       334.1       17.6
Net purchase of subsidiary shares from noncontrolling interests (0.3)     (0.2)         (0.1)
Dividends paid to noncontrolling interests (11.0)               (11.0)
Net change in pension asset/liability, net of taxes 1.6           1.6    
Foreign currency translation, net of taxes 75.1           74.5   0.6
Change in fair value of derivative investments, net of taxes (11.8)           (11.8)    
Compensation expense related to stock option plan grants 3.6     3.6          
Common stock issued in: purchase transactions 37.0   $ 0.5 36.5          
Common stock issued in: purchase transactions (in shares)     500,000            
Stock option plans 28.1   $ 0.7 27.4          
Stock option plans (in shares)     700,000            
Employee stock purchase plan 4.7   $ 0.1 4.6          
Employee stock purchase plan (in shares)     100,000            
Deferred compensation and restricted stock (7.5)     (7.5)          
Cash dividends declared on common stock (80.3)       (80.3)        
Ending balance at Mar. 31, 2019 4,958.2   $ 185.3 3,606.3 1,810.2   (721.5)   77.9
Ending balance, (in shares) at Mar. 31, 2019     185,300,000            
Beginning balance at Dec. 31, 2018 4,569.7 $ (2.4) $ 184.0 3,541.9 1,558.6 $ (2.2) (785.6) $ (0.2) 70.8
Beginning balance (in shares) at Dec. 31, 2018     184,000,000.0            
Net earnings 610.2                
Net change in pension asset/liability, net of taxes 3.4                
Change in fair value of derivative investments, net of taxes (57.8)                
Compensation expense related to stock option plan grants 10.5                
Ending balance at Sep. 30, 2019 4,912.0   $ 186.5 3,697.7 1,884.2   (925.1)   68.7
Ending balance, (in shares) at Sep. 30, 2019     186,500,000            
Beginning balance at Mar. 31, 2019 4,958.2   $ 185.3 3,606.3 1,810.2   (721.5)   77.9
Beginning balance (in shares) at Mar. 31, 2019     185,300,000            
Net earnings 121.4       110.1       11.3
Net purchase of subsidiary shares from noncontrolling interests (7.3)               (7.3)
Dividends paid to noncontrolling interests (13.3)               (13.3)
Net change in pension asset/liability, net of taxes 0.8           0.8    
Foreign currency translation, net of taxes (60.9)           (60.7)   (0.2)
Change in fair value of derivative investments, net of taxes (21.1)           (21.1)    
Compensation expense related to stock option plan grants 3.5     3.5          
Common stock issued in: purchase transactions 11.0   $ 0.1 10.9          
Common stock issued in: purchase transactions (in shares)     100,000            
Stock option plans 21.8   $ 0.5 21.3          
Stock option plans (in shares)     500,000            
Employee stock purchase plan 10.5   $ 0.1 10.4          
Employee stock purchase plan (in shares)     100,000            
Deferred compensation and restricted stock 4.2   $ 0.1 4.1          
Deferred compensation and restricted (in shares)     100,000            
Cash dividends declared on common stock (81.0)       (81.0)        
Ending balance at Jun. 30, 2019 4,947.8   $ 186.1 3,656.5 1,839.3   (802.5)   68.4
Ending balance, (in shares) at Jun. 30, 2019     186,100,000            
Net earnings 137.1       126.1       11.0
Net purchase of subsidiary shares from noncontrolling interests 0.9               0.9
Dividends paid to noncontrolling interests (8.5)               (8.5)
Net change in pension asset/liability, net of taxes 1.0           1.0    
Foreign currency translation, net of taxes (101.8)           (98.7)   (3.1)
Change in fair value of derivative investments, net of taxes (24.9)           (24.9)    
Compensation expense related to stock option plan grants 3.4     3.4          
Common stock issued in: purchase transactions 9.0   $ 0.1 8.9          
Common stock issued in: purchase transactions (in shares)     100,000            
Stock option plans 11.8   $ 0.2 11.6          
Stock option plans (in shares)     200,000            
Employee stock purchase plan 6.2   $ 0.1 6.1          
Employee stock purchase plan (in shares)     100,000            
Deferred compensation and restricted stock 11.2     11.2          
Cash dividends declared on common stock (81.2)       (81.2)        
Ending balance at Sep. 30, 2019 4,912.0   $ 186.5 3,697.7 1,884.2   (925.1)   68.7
Ending balance, (in shares) at Sep. 30, 2019     186,500,000            
Beginning balance at Dec. 31, 2019 $ 5,215.5   $ 188.1 3,825.7 1,901.3   (759.6)   60.0
Beginning balance (in shares) at Dec. 31, 2019 188,100,000   188,100,000            
Net earnings $ 355.4       346.3       9.1
Net purchase of subsidiary shares from noncontrolling interests (10.8)               (10.8)
Dividends paid to noncontrolling interests (18.9)               (18.9)
Net change in pension asset/liability, net of taxes 1.2           1.2    
Foreign currency translation, net of taxes (380.1)           (381.3)   1.2
Change in fair value of derivative investments, net of taxes (91.4)           (91.4)    
Compensation expense related to stock option plan grants 3.4     3.4          
Common stock issued in: purchase transactions 73.1   $ 0.7 72.4          
Common stock issued in: purchase transactions (in shares)     700,000            
Stock option plans 17.9   $ 0.4 17.5          
Stock option plans (in shares)     400,000            
Employee stock purchase plan 6.0   $ 0.1 5.9          
Employee stock purchase plan (in shares)     100,000            
Deferred compensation and restricted stock (15.0)   $ 0.3 (15.3)          
Deferred compensation and restricted (in shares)     300,000            
Cash dividends declared on common stock (86.2)       (86.2)        
Ending balance at Mar. 31, 2020 5,070.1   $ 189.6 3,909.6 2,161.4   (1,231.1)   40.6
Ending balance, (in shares) at Mar. 31, 2020     189,600,000            
Beginning balance at Dec. 31, 2019 $ 5,215.5   $ 188.1 3,825.7 1,901.3   (759.6)   60.0
Beginning balance (in shares) at Dec. 31, 2019 188,100,000   188,100,000            
Net earnings $ 705.0                
Net change in pension asset/liability, net of taxes 1.6                
Change in fair value of derivative investments, net of taxes (83.7)                
Compensation expense related to stock option plan grants $ 10.1                
Stock option plans (in shares) 1,200,000                
Ending balance at Sep. 30, 2020 $ 5,818.2   $ 192.3 4,132.5 2,317.3   (870.4)   46.5
Ending balance, (in shares) at Sep. 30, 2020 192,300,000   192,300,000            
Beginning balance at Mar. 31, 2020 $ 5,070.1   $ 189.6 3,909.6 2,161.4   (1,231.1)   40.6
Beginning balance (in shares) at Mar. 31, 2020     189,600,000            
Net earnings 161.8       153.7       8.1
Net purchase of subsidiary shares from noncontrolling interests 4.3               4.3
Dividends paid to noncontrolling interests (6.3)               (6.3)
Foreign currency translation, net of taxes 249.9           250.7   (0.8)
Change in fair value of derivative investments, net of taxes (1.8)           (1.8)    
Compensation expense related to stock option plan grants 3.3     3.3          
Common stock issued in: purchase transactions 110.9   $ 1.2 109.7          
Common stock issued in: purchase transactions (in shares)     1,200,000            
Stock option plans 21.9   $ 0.5 21.4          
Stock option plans (in shares)     500,000            
Employee stock purchase plan 12.4   $ 0.1 12.3          
Employee stock purchase plan (in shares)     100,000            
Deferred compensation and restricted stock (5.2)   $ 0.1 (5.3)          
Deferred compensation and restricted (in shares)     100,000            
Cash dividends declared on common stock (86.8)       (86.8)        
Ending balance at Jun. 30, 2020 5,534.5   $ 191.5 4,051.0 2,228.3   (982.2)   45.9
Ending balance, (in shares) at Jun. 30, 2020     191,500,000            
Net earnings 187.8       176.6       11.2
Net purchase of subsidiary shares from noncontrolling interests (0.8)               (0.8)
Dividends paid to noncontrolling interests (10.3)               (10.3)
Net change in pension asset/liability, net of taxes 0.4           0.4    
Foreign currency translation, net of taxes 102.4           101.9   0.5
Change in fair value of derivative investments, net of taxes 9.5           9.5    
Compensation expense related to stock option plan grants 3.4     3.4          
Common stock issued in: purchase transactions 39.0   $ 0.4 38.6          
Common stock issued in: purchase transactions (in shares)     400,000            
Stock option plans 17.2   $ 0.3 16.9          
Stock option plans (in shares)     300,000            
Employee stock purchase plan 8.1   $ 0.1 8.0          
Employee stock purchase plan (in shares)     100,000            
Deferred compensation and restricted stock 14.6     14.6          
Cash dividends declared on common stock (87.6)       (87.6)        
Ending balance at Sep. 30, 2020 $ 5,818.2   $ 192.3 $ 4,132.5 $ 2,317.3   $ (870.4)   $ 46.5
Ending balance, (in shares) at Sep. 30, 2020 192,300,000   192,300,000